Dr. Matthew Katz
Overview
Matthew S. Katz, MD, is a fellowship-trained interventional cardiologist with Atlantic Medical Group. Board-certified in internal medicine and cardiovascular disease by the American Board of Internal Medicine, he has expertise treating patients with a wide variety of cardiovascular conditions using small, flexible tubes called catheters to detect, reach and repair damaged or weakened vessels, open blockages in narrowed arteries, and insert stents to keep the arteries open.Dr. Katz believes in providing compassionate care to his patients using minimally invasive techniques to treat coronary artery disease, peripheral vascular disease, valvular heart disease, and structural heart disease. These techniques prevent the need for open-heart surgery, reducing risks and leading to a faster recovery for patients.Dr. Katz earned his medical degree from Hofstra North Shore-LIJ School of Medicine, Hempstead, NY, where he was named to the Gold Humanism Honor Society for compassion and excellence in medicine and to the Alpha Omega Alpha Medicine Honor Society for academic performance. He performed his internal medicine residency at the Icahn School of Medicine at Mount Sinai in New York City, where he was named chief resident. He followed that with a clinical cardiology fellowship at the Mayo Clinic in Rochester, MN, and then a second fellowship in interventional cardiology at New York-Presbyterian/Weill Cornell Medical Center, also in New York.The author of multiple publications in peer-reviewed medical journals, Dr. Katz has also participated in research on transcatheter aortic valve replacement (TAVR) and kidney disease and transcatheter mitral valve replacement. He is a participating provider of the Atlantic Accountable Care Organization.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- MEDICARE SNP
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
571 Central Avenue, Suite 115, New Providence, NJ 07974
211 Mountain Avenue, Suite 300, Springfield, NJ 07081
Morristown Medical Center
An internationally recognized leader in structural heart disease, Dr. Généreux has been a practicing interventional cardiologist for more than 15 years. He is the director of the structural heart program at Morristown Medical Center, has served as the primary or co-investigator on more than 20 clinical trials, and has published more than 350 articles in peer-reviewed journals. He is currently the principal investigator of the EARLY TAVR trial and the PROGRESS trial, two major studies in the field of aortic valve disease. A celebrated clinical researcher since the beginning of his career, he was awarded the prestigious Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium and has been named a Highly Cited Researcher by the Clarivate™ Web of Science™ Group for the last four years. Dr. Généreux is also involved in multiple early-stage companies in the field of interventional cardiology and heart failure. He received his medical degree from the Université de Montréal, Montréal, Québec, Canada, his cardiology and interventional cardiology degrees from Université de Sherbrooke and Sacré-Coeur Hospital, Montreal, Canada, and performed his advanced interventional cardiology and structural heart fellowship at Columbia University and Cardiovascular Research Foundation, in New York city. Dr. Genereux is highly rated in 17 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Coronary Heart Disease, Aortic Valve Replacement, and Percutaneous Coronary Intervention (PCI).
Atlantic Medical Group Valve Center
Dr. Gennaro Giustino is an Interventional Cardiologist with coronary, endovascular and structural heart disease training. He completed his Internal Medicine Residency, Cardiovascular Medicine and Interventional Cardiology Fellowship at The Mount Sinai Hospital - Icahn School of Medicine in New York, during which he served as Chief Fellow under Dr Valentin Fuster. Then, he went to complete an advanced fellowship in Structural Heart Disease and Mechanical Cardiocirculatory Support at Henry Ford Heart and Vascular Institute under Dr William O'Neill. He has published more than 300 peer-reviewed manuscripts and abstracts in cardiovascular medicine. In addition, he has participated in the inception, design and conduction of multiple randomized controlled trials and registries resulting in publications in the most prestigious journals including The New England Journal of Medicine, The Lancet, the Journal of the American College of Cardiology (JACC) and Circulation. He is also routinely invited as a faculty at international conferences and as a peer-reviewer for leading scientific journals. He is board-certified in Internal Medicine, Cardiovascular Medicine, Interventional Cardiology, Echocardiography and Cardiac Computed Tomography. He also speaks multiple languages, including Spanish, Italian, and French. Dr. Giustino is highly rated in 19 conditions, according to our data. His top areas of expertise are Heart Attack, Coronary Heart Disease, Aortic Valve Stenosis, Percutaneous Coronary Intervention (PCI), and Transcatheter Aortic Valve Replacement (TAVR).
Chs Physician Partners PC
Evan Shlofmitz is an Interventional Cardiologist and a Cardiologist in Roslyn, New York. Dr. Shlofmitz is highly rated in 9 conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Angina, Atherosclerosis, Atherectomy, and Angioplasty.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
We do not have enough information to identify the Areas of Expertise for this provider.